3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
21
Recurrence
8
Lymphoma, Large B-Cell, Diffuse
7
Leukemia, Myeloid, Acute
4
Sarcoma
3
Endometrial Neoplasms
3
Primary Myelofibrosis
2
Neurofibrosarcoma
2
Neoplasms
2
Myeloproliferative Disorders
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Extranodal NK-T-Cell
2
Lymphoma, B-Cell
2
Glioblastoma
2
Wilms Tumor
1
Waldenstrom Macroglobulinemia
1
Vascular Neoplasms
1
Uterine Neoplasms
1
Uterine Diseases
1
Triple Negative Breast Neoplasms
1
Solitary Fibrous Tumors
1
Smooth Muscle Tumor
1
Sarcoma, Clear Cell
1
Sarcoma, Alveolar Soft Part
1
Salivary Gland Neoplasms
1
Rhabdoid Tumor
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Osteosarcoma
1
Nerve Sheath Neoplasms
1
Neoplasms, Adipose Tissue
1
Interventions
Temozolomide
12
Vincristine
9
Irinotecan
8
Cyclophosphamide
8
cabozantinib
6
X-Rays
5
Specimen Handling
5
Magnetic Resonance Spectroscopy
5
Etoposide
5
regorafenib
4
fludarabine
4
Radiotherapy
4
Phantoms, Imaging
4
Ifosfamide
4
Doxorubicin
4
Radiation
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
liposomal doxorubicin
2
ivosidenib
2
irinotecan sucrosofate
2
etoposide phosphate
2
abemaciclib
2
Zoledronic Acid
2
Topotecan
2
Surgical Procedures, Operative
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma, Ewing
×
selinexor
×
1 year
×
Clear all
No trials found.